Quarterly Financials Review
ADJUSTED EBITDA RECONCILIATION
($ in thousands)
Net income (loss)
Depreciation and amortization
Interest expense, net
Income tax expense (benefit)
EBITDA
Equity-based compensation
COVID-19: "thank you pay" and catastrophic leave
COVID-19: prepaid costs not utilized
Milestone events
Executive transition costs
TRA remeasurement
Legal proceedings
Adjusted EBITDA
Adjusted EBITDA margin
18
2022
2023
Q1
Q2
Q3
Q4
Q1
Q2
$(16,279) $ (1,751)
$ 1,594
$ (2,817)
$ (9,391) $ 9,711
9,182
10,539
11,810
13,197
14,779
16,516
2,489
3,596
5,011
6,922
7,886
9,058
(214)
$ (4,822) $13,269
950
9,900 10,446
224
885 (3,371) 5,299
$15,044 $22,601 $15,854
10,649
9,170
227
2,580
1,851
$37,136
10,662
10,149
1,200
67
1,105
2,434
1,910
691
(5,376)
150
(1,294)
225
(861)
1,950
$ 9,662
6.4 %
$23,939
12.8 %
$27,830
14.0 %
$29,750
14.7 %
$23,880
12.1 %
$48,599
19.4 %View entire presentation